Age-related cardiopathies gene editing.
作者信息
Song Moshi, Belmonte Juan Carlos Izpisua, Liu Guang-Hui
机构信息
State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
Institute for Stem cell and Regeneration, CAS, Beijing 100101, China.
出版信息
Aging (Albany NY). 2019 Mar 10;11(5):1327-1328. doi: 10.18632/aging.101853.
Abstract
摘要
相似文献
1
Age-related cardiopathies gene editing.
Aging (Albany NY). 2019 Mar 10;11(5):1327-1328. doi: 10.18632/aging.101853.
2
Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases.
Neurol Sci. 2018 Nov;39(11):1827-1835. doi: 10.1007/s10072-018-3521-0. Epub 2018 Aug 3.
3
Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
mSphere. 2018 Jun 13;3(3). doi: 10.1128/mSphereDirect.00208-18. Print 2018 Jun 27.
4
Recent Advances in CRISPR/Cas9-Mediated Genome Editing in .
Cells. 2019 Jan 12;8(1):46. doi: 10.3390/cells8010046.
5
Efficient SSA-mediated precise genome editing using CRISPR/Cas9.
FEBS J. 2018 Sep;285(18):3362-3375. doi: 10.1111/febs.14626. Epub 2018 Aug 25.
6
CRISPR/Cas9 therapeutics for liver diseases.
J Cell Biochem. 2018 Jun;119(6):4265-4278. doi: 10.1002/jcb.26627. Epub 2018 Feb 22.
7
How genome editing could be used in the treatment of cardiovascular diseases.
Per Med. 2018 Mar;15(2):67-69. doi: 10.2217/pme-2017-0078. Epub 2018 Feb 2.
8
Efficient CRISPR/Cas9-based genome editing and its application to conditional genetic analysis in Marchantia polymorpha.
PLoS One. 2018 Oct 31;13(10):e0205117. doi: 10.1371/journal.pone.0205117. eCollection 2018.
9
In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges.
Bioconjug Chem. 2017 Apr 19;28(4):880-884. doi: 10.1021/acs.bioconjchem.7b00057. Epub 2017 Mar 17.
10
CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
Chem Rev. 2017 Aug 9;117(15):9874-9906. doi: 10.1021/acs.chemrev.6b00799. Epub 2017 Jun 22.
本文引用的文献
1
At the Heart of Genome Editing and Cardiovascular Diseases.
Circ Res. 2018 Jul 6;123(2):221-223. doi: 10.1161/CIRCRESAHA.118.312676.
2
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration.
Cell. 2018 Mar 22;173(1):104-116.e12. doi: 10.1016/j.cell.2018.02.014. Epub 2018 Mar 1.
3
In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation.
Cell. 2017 Dec 14;171(7):1495-1507.e15. doi: 10.1016/j.cell.2017.10.025. Epub 2017 Dec 7.
4
Cardiac aging and heart disease in humans.
Biophys Rev. 2017 Apr;9(2):131-137. doi: 10.1007/s12551-017-0255-9. Epub 2017 Mar 20.
5
The Aging Heart.
Cold Spring Harb Perspect Med. 2015 Sep 1;5(9):a025148. doi: 10.1101/cshperspect.a025148.
6
Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells.
Nat Biotechnol. 2015 May;33(5):543-8. doi: 10.1038/nbt.3198. Epub 2015 Mar 24.
7
Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining.
Nat Biotechnol. 2015 May;33(5):538-42. doi: 10.1038/nbt.3190. Epub 2015 Mar 23.
8
Perspectives on mammalian cardiovascular aging: humans to molecules.
Comp Biochem Physiol A Mol Integr Physiol. 2002 Aug;132(4):699-721. doi: 10.1016/s1095-6433(02)00124-1.
Zotero 插件